Cargando…
Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD
Background: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease where liver biopsy remains the gold standard for diagnosis. Here we aimed to evaluate the role of circulating adiponectin, leptin, and insulin-like growth factor 1 (IGF-1) levels as non-invasive NAFLD bioma...
Autores principales: | Marques, Vanda, Afonso, Marta B., Bierig, Nina, Duarte-Ramos, Filipa, Santos-Laso, Álvaro, Jimenez-Agüero, Raul, Eizaguirre, Emma, Bujanda, Luis, Pareja, Maria J., Luís, Rita, Costa, Adília, Machado, Mariana V., Alonso, Cristina, Arretxe, Enara, Alustiza, José M., Krawczyk, Marcin, Lammert, Frank, Tiniakos, Dina G., Flehmig, Bertram, Cortez-Pinto, Helena, Banales, Jesus M., Castro, Rui E., Normann, Andrea, Rodrigues, Cecília M. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260936/ https://www.ncbi.nlm.nih.gov/pubmed/34249975 http://dx.doi.org/10.3389/fmed.2021.683250 |
Ejemplares similares
-
RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease
por: Afonso, Marta B, et al.
Publicado: (2021) -
Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery
por: Jiménez-Agüero, Raúl, et al.
Publicado: (2014) -
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
por: Lewinska, Monika, et al.
Publicado: (2021) -
Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis
por: Banales, Jesus M., et al.
Publicado: (2019) -
A Novel Serum Metabolomic Profile for the Differential Diagnosis of Distal Cholangiocarcinoma and Pancreatic Ductal Adenocarcinoma
por: Macias, Rocio I.R., et al.
Publicado: (2020)